Cargando…
PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428885/ http://dx.doi.org/10.1097/01.HS9.0000976748.46081.72 |
| _version_ | 1785090577566531584 |
|---|---|
| author | Abboud, Miguel Kanter, Julie Marfo, Kwaku Anthony, Charmaine Lincy, Jeremie Nassin, Michele Joshi, Vikas Brueckner, Andreas Keefe, Deborah Ataga, Kenneth I. |
| author_facet | Abboud, Miguel Kanter, Julie Marfo, Kwaku Anthony, Charmaine Lincy, Jeremie Nassin, Michele Joshi, Vikas Brueckner, Andreas Keefe, Deborah Ataga, Kenneth I. |
| author_sort | Abboud, Miguel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428885 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104288852023-08-17 PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS Abboud, Miguel Kanter, Julie Marfo, Kwaku Anthony, Charmaine Lincy, Jeremie Nassin, Michele Joshi, Vikas Brueckner, Andreas Keefe, Deborah Ataga, Kenneth I. Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428885/ http://dx.doi.org/10.1097/01.HS9.0000976748.46081.72 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Abboud, Miguel Kanter, Julie Marfo, Kwaku Anthony, Charmaine Lincy, Jeremie Nassin, Michele Joshi, Vikas Brueckner, Andreas Keefe, Deborah Ataga, Kenneth I. PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS |
| title | PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS |
| title_full | PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS |
| title_fullStr | PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS |
| title_full_unstemmed | PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS |
| title_short | PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS |
| title_sort | pb2512: safety of crizanlizumab in patients with sickle cell disease: integrated post-marketing surveillance analysis |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428885/ http://dx.doi.org/10.1097/01.HS9.0000976748.46081.72 |
| work_keys_str_mv | AT abboudmiguel pb2512safetyofcrizanlizumabinpatientswithsicklecelldiseaseintegratedpostmarketingsurveillanceanalysis AT kanterjulie pb2512safetyofcrizanlizumabinpatientswithsicklecelldiseaseintegratedpostmarketingsurveillanceanalysis AT marfokwaku pb2512safetyofcrizanlizumabinpatientswithsicklecelldiseaseintegratedpostmarketingsurveillanceanalysis AT anthonycharmaine pb2512safetyofcrizanlizumabinpatientswithsicklecelldiseaseintegratedpostmarketingsurveillanceanalysis AT lincyjeremie pb2512safetyofcrizanlizumabinpatientswithsicklecelldiseaseintegratedpostmarketingsurveillanceanalysis AT nassinmichele pb2512safetyofcrizanlizumabinpatientswithsicklecelldiseaseintegratedpostmarketingsurveillanceanalysis AT joshivikas pb2512safetyofcrizanlizumabinpatientswithsicklecelldiseaseintegratedpostmarketingsurveillanceanalysis AT bruecknerandreas pb2512safetyofcrizanlizumabinpatientswithsicklecelldiseaseintegratedpostmarketingsurveillanceanalysis AT keefedeborah pb2512safetyofcrizanlizumabinpatientswithsicklecelldiseaseintegratedpostmarketingsurveillanceanalysis AT atagakennethi pb2512safetyofcrizanlizumabinpatientswithsicklecelldiseaseintegratedpostmarketingsurveillanceanalysis |